投資評等
最後更新日期:2024/11/8
升級(Upgrade)
日期/Date | 券商 Brokerage Firm | 原評等->升級後評等 Upgrade from: -> to: | 新目標價 New Target |
2013/12/3 | UBS | Neutral >> Buy | $540 >> $650 |
2013/10/29 | Robert W. Baird | Neutral >> Outperform | $525 >> $620 |
2009/10/2 | UBS | Neutral >> Buy | $170 >> $265 |
2009/9/10 | JMP Securities | Mkt Perform >> Mkt Outperform | 200 |
2009/7/22 | Canaccord Adams | Hold >> Buy | |
2009/6/3 | Collins Stewart | Hold >> Buy | |
2009/4/23 | Morgan Keegan | Mkt Perform Outperform | |
2009/4/23 | RBC Capital Mkts | Underperform Outperform | |
2008/4/7 | Thomas Weisel | Market Weight Overweight | $188 $195 |
2005/8/15 | Caris Company | Average->Above Average | |
2005/4/25 | CSFB | Neutral->Outperform | 45 |
2005/1/13 | Prudential | Neutral->Overweight | 93 |
2005/1/13 | Banc of America Sec | Neutral->Buy | |
2005/1/12 | Needham Co | Hold->Buy | |
2004/10/14 | Bear Stearns | Peer Perform->Outperform | 52 |
2004/10/14 | JP Morgan | Neutral->Overweight | |
2004/10/4 | Caris Company | Above Average->Buy | |
2004/7/2 | Smith Barney Citigroup | Hold->Buy | 37 |
2004/6/28 | Piper Jaffray | Market Perform->Outperform | $40 |
2004/4/15 | Smith Barney Citigroup | Sell->Hold | |
2004/3/22 | FTN Midwest | Neutral->Buy | 30 |
2004/1/15 | UBS | Neutral->Buy | 28 |
2004/1/13 | Thomas Weisel | Peer Perform->Outperform | |
2003/9/29 | Lehman Brothers | Equal-weight -> Overweight | 24 |
2003/6/24 | Merrill Lynch | Sell -> Neutral | |
2003/6/18 | Needham & Co | Hold -> Buy | 23 |
2003/5/8 | Smith Barney Citigroup | Underperform -> In-line | 18 |
降級(Downgrade)
日期/Date | 券商 Brokerage Firm | 原評等->降級後評等 Upgrade from: -> to: | 新目標價 New Target |
2015/1/15 | Mizuho | Buy >> Neutral | 115 |
2014/10/4 | Deutsche Bank | Buy >> Hold | $105 >> $102 |
2014/2/20 | Barclays | Overweight >> Equal Weight | $570 >> $570 |
2013/8/2 | Standpoint Research | Buy >> Hold | |
2011/3/16 | JMP Securities | Mkt Outperform >> Mkt Perform | |
2009/4/23 | Collins Stewart | Buy Hold | |
2006/10/2 | Citigroup | Buy Hold | |
2005/12/14 | Banc of America Sec | Buy->Neutral | 52 |
2005/12/14 | Bear Stearns | Outperform->Peer Perform | |
2005/11/7 | Needham Co | Buy->Hold | |
2005/11/4 | Prudential | Overweight->Neutral | |
2005/4/14 | AmTech Research | Buy->Hold | |
2005/4/11 | Caris Company | Above Average->Average | |
2005/2/11 | Caris Company | Buy->Above Average | |
2004/12/6 | Thomas Weisel | Outperform->Peer Perform | |
2004/12/3 | Needham Co | Buy->Hold | |
2004/12/2 | Smith Barney Citigroup | Buy->Hold | 60 |
2003/1/16 | Needham & Co | Buy -> Hold | |
首次予以評等(Coverage Initiated)
日期/Date | 券商 Brokerage Firm | 原評等->升級後評等 Upgrade from: -> to: | 目標股價 |
2014/4/10 | Deutsche Bank | Buy | 650 |
2013/4/19 | Standpoint Research | Buy | 480 |
2012/7/11 | UBS | Buy | 740 |
2012/2/9 | Mizuho | Buy | 635 |
2011/8/15 | Hilliard Lyons | Buy | 475 |
2011/1/5 | Wedbush | Outperform | 405 |
2011/1/4 | Brigantine | Buy | 400 |
2010/11/4 | Robert W. Baird | Outperform | 410 |
2010/10/5 | Jefferies | Buy | 365 |
2010/10/4 | Ticonderoga | Buy | 430 |
恢復投資評等(Coverage Resumed)
日期/Date | 券商/Brokerage Firm | 恢復評等後等級/Resumed Rating | 目標股價Target |
2015/9/22 | Goldman | Buy | 163 |
2014/9/3 | Oppenheimer | Perform | |
2012/4/19 | Canaccord Genuity | Buy | $710 >> $740 |
2011/5/4 | Oppenheimer | Outperform | $465 >> $450 |
2010/9/1 | JMP Securities | Mkt Outperform | 290 |
2003/1/7 | Merrill Lynch | Sell | |
重申相同投資評等(Coverage Reiterated)
日期/Date | 券商 Brokerage Firm | 重申相同投資評等 Reiterated Rating | 新目標價 New Target |
2015/12/14 | Barclays | Overweight | $155 >> $150 |
2014/12/1 | Barclays | Overweight | $120 >> $140 |
2014/11/11 | UBS | Buy | $115 >> $125 |
2014/10/21 | Argus | Buy | $110 >> $120 |
2014/10/14 | Monness Crespi & Hardt | Buy | $100 >> $115 |
2014/9/10 | Barclays | Overweight | $110 >> $116 |
2014/6/13 | BMO Capital Markets | Outperform | |
2014/5/28 | Barclays | Equal Weight | $590 >> $655 |
2013/12/23 | Stifel | Buy | $600 >> $650 |
2013/8/21 | UBS | Buy | $500 >> $560 |